These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28351734)

  • 1. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.
    Akbar SM; Al-Mahtab M; Khan MS
    Expert Opin Biol Ther; 2013 Jul; 13(7):1063-74. PubMed ID: 23581572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.
    Michel ML; Deng Q; Mancini-Bourgine M
    J Hepatol; 2011 Jun; 54(6):1286-96. PubMed ID: 21238516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?
    Michel ML; Bourgine M; Fontaine H; Pol S
    Med Microbiol Immunol; 2015 Feb; 204(1):121-9. PubMed ID: 25511871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.
    Zhang E; Kosinska A; Lu M; Yan H; Roggendorf M
    Antiviral Res; 2015 Nov; 123():193-203. PubMed ID: 26476376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
    Roggendorf M; Schulte I; Xu Y; Lu M
    J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into immunotherapy for hepatitis B patients.
    Akbar SM; Al-Mahtab M; Jahan M; Yoshida O; Hiasa Y
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):267-76. PubMed ID: 26626120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress of therapeutic vaccines for treating chronic hepatitis B.
    Li J; Bao M; Ge J; Ren S; Zhou T; Qi F; Pu X; Dou J
    Hum Vaccin Immunother; 2017 May; 13(5):986-997. PubMed ID: 28118084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
    Lau GK
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.
    Yang SH; Lee CG; Park SH; Im SJ; Kim YM; Son JM; Wang JS; Yoon SK; Song MK; Ambrozaitis A; Kharchenko N; Yun YD; Kim CM; Kim CY; Lee SH; Kim BM; Kim WB; Sung YC
    Gene Ther; 2006 Jul; 13(14):1110-7. PubMed ID: 16525482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic HBV vaccine drives immune responses in liver.
    Hum Vaccin Immunother; 2013 Jan; 9(1):7-8. PubMed ID: 23570047
    [No Abstract]   [Full Text] [Related]  

  • 16. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
    Chang KM; Liu M
    Curr Opin Pharmacol; 2016 Oct; 30():93-105. PubMed ID: 27570126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy.
    Yang FQ; Yu YY; Wang GQ; Chen J; Li JH; Li YQ; Rao GR; Mo GY; Luo XR; Chen GM
    J Viral Hepat; 2012 Aug; 19(8):581-93. PubMed ID: 22762143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.